EndoGastric Solutions hopes to chase reimbursement and publish data from a trio of clinical trials with funds from a $30 million Series G financing round.
California-based EndoGastric Solutions touted $30 million raised in a Series G fundraising round in support of its acid reflux treatment device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1inmdCm
Cap comentari:
Publica un comentari a l'entrada